In vivo generated afatinib-resistant clones of H1975 lung cancer cells showed decreased expression of EGFR, HER2, HER3 and HER4 and increased expression of MET, c-KIT and PDGFRβ. This evidence concerns the gene ERBB3 and lung cancer.